Pfizer (PFE) Stock Rallies on November 21, 2025 as Investors Focus on FDA Win, Obesity Pivot and 7% Dividend Yield
New York – November 21, 2025 Pfizer (NYSE: PFE) finished Friday’s session on a strong note, with the stock climbing as investors digested a fresh U.S. FDA approval in bladder cancer, progress in obesity drugs, a multi‑billion‑dollar bond sale and one of the highest dividend yields among mega‑cap healthcare names. Below is a deep dive into how PFE traded today, what’s driving sentiment, and what to watch next if you follow Pfizer stock. PFE stock today: price action and trading snapshot On Friday, November 21, 2025, Pfizer shares: Pfizer outperformed several large‑cap pharma peers on the day, beating Johnson &